wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33387519-A3ABFD43-0404-4EBA-A406-C8F7EB9ACF38
Q33387519-A3ABFD43-0404-4EBA-A406-C8F7EB9ACF38
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33387519-A3ABFD43-0404-4EBA-A406-C8F7EB9ACF38
Nilotinib as front-line treatment for patients with chronic myeloid leukemia in early chronic phase.
P2860
Q33387519-A3ABFD43-0404-4EBA-A406-C8F7EB9ACF38
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33387519-A3ABFD43-0404-4EBA-A406-C8F7EB9ACF38
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
f3e4926352012ad4fc4a675c14736fb1289df594
P2860
Phase III, randomized, open-label study of daily imatinib mesylate 400 mg versus 800 mg in patients with newly diagnosed, previously untreated chronic myeloid leukemia in chronic phase using molecular end points: tyrosine kinase inhibitor optimizati